Table 2 Case reports with spontaneous intragastric balloon hyperinflation
First author (year) | Age (years) | Sex | Initial BMI (kg/m2) | Type of IGB | Filling volume (ml) | MB use | Hyperinflation symptomsa | Timing of symptoms post-placement (months) | Management | Management outcome | IGB fluid culture |
|---|---|---|---|---|---|---|---|---|---|---|---|
Madeira (2013) [28] | 45 | F | 37.4 | SB | 650 | Yes | N/V, AP/AD | 4 | ER | CR | Klebsiella Pnemoniae, Candida spp. |
Patel (2014) [30] | 61 | F | NR | SB | 500 | NR | N/V, AP/AD | 5 | ER | CR | No growth |
Marques (2015) [29] | 37 | F | 35 | Adj. SB | NR | Yes | N/V, EAP, PP fullness | 2 | Nystatin and MB refillb | CR | Candida spp. |
Barola (2017) [26] | 45 | F | 32 | SB | 650 | Yes | N/V, GER | 5 | ER | NR | Not obtained |
De Quadros (2018) [24] | 46 | F | 31.6 | SB | NR | NR | EAP/AD, N/V | 3 | ER | CR | Not obtained |
Lopez-Nava (2019) [27] | 42 | F | 31 | SB | 650 | Yes | N/V, AP/AD | 2 | ER | CR | Candida parapsilosis |
Quarta (2019) [25] | 62 | F | 32 | SB | NR | NR | EAP | 5 | ER | NR | Klebsiella spp., Streptococcus, Candida spp. |
Barrichello (2020) [23] | 53 | F | 30.2 | SB | 700 | NR | AP | 1.5 | ER | CR | Not obtained |
Basile (2020) [15] | 42 | F | 37 | SB | 700 | NR | AP/AD, N/V, GER | 4 | ER | NR | Not obtained |
Usuy (2020) [31] | 62 | F | 30 | Adj.SB | 500 | Yes | EAP/AD, N/V | 3.5 | Amoxicillin and MB refillb | NR | Streptococcus viridans |
| Â | 38 | F | 28 | Adj. SB | 500 | Yes | EAP/AD | 2.5 | ERc | NR | Candida spp. |